株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品包装産業

Pharmaceutical Packaging to 2021

発行 Allied Development Corp. 商品コード 235030
出版日 ページ情報 英文 400 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
医薬品包装産業 Pharmaceutical Packaging to 2021
出版日: 2016年11月21日 ページ情報: 英文 400 Pages
概要

世界の医薬品包装産業は、2016年、一次包装金額で106億米ドルに達すると予測されています。

当レポートでは、世界の医薬品包装産業について調査分析し、技術、市場動向と予測、包装メーカー、装置サプライヤーなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 技術

  • 技術の優先順位
  • デバイス vs. 包装の定義
  • 一次包装
  • 二次包装
  • 小児用安全包装
  • コンプライアンス包装
  • 開封明示包装
  • 単位用量包装
  • 偽造防止包装
  • 表示
  • ID・追跡
  • 活性包装
  • 無菌医薬品の充填プロセス
  • 非無菌医薬品の充填プロセス
  • 医薬品包装材料
  • 医薬品包装構造
  • 医薬品包装装置技術

第3章 市場動向と予測

  • 製薬業の促進要因と動向
  • 医薬品包装産業の促進要因と動向
  • 世界の一次包装容量:送達方法別
  • 世界の一次包装容量:包装タイプ別
  • 世界の一次包装金額:包装タイプ別
  • アジアの一次包装容量:包装タイプ別
  • 中国の一次包装容量:包装タイプ別
  • 欧州の一次包装容量:包装タイプ別
  • 日本の一次包装容量:包装タイプ別
  • 北米の一次包装容量:包装タイプ別
  • その他の地域の一次包装容量:包装タイプ別
  • 世界の一次包装容量:地域別
  • 世界の一次包装金額:地域別
  • 世界の二次包装容量:包装タイプ別
  • 世界の二次包装金額:包装タイプ別
  • 一次包装容量:規制状況別
  • 一次包装容量:薬剤生産工程別
  • 一次包装容量:流通経路別
  • 一次包装容量:コンプライアンス機能別
  • 一次包装容量:偽造防止別
  • 一次包装容量:小児用安全別
  • 一次包装容量:開封明示別
  • 一次包装容量:材料タイプ別

第4章 包装メーカー

第5章 装置サプライヤー

第6章 用語集

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: RPP16A

"Pharmaceutical Packaging to 2021" examines the global pharmaceutical packaging industry, which will reach US$10.6 billion in primary packaging value in 2016. This comprehensive study examines industry technology, industry participants, and market trends in order to forecast the market through 2021.

This large packaging market will continue to grow due to:

  • the growing market of aged consumers
  • government regulations driving huge programs such as serialization
  • innovative packages for child resistance
  • new technology for packages that ensure patients adhere to their drug regimens
  • increasing demands from more sophisticated pharmaceuticals
  • increasing demands from new drug delivery systems

Quantitative forecasts include primary packaging, secondary packaging, by geographic region, child-resistance, patient compliance, and many others.

Table of Contents

Section I: Introduction

  • A. Pharmaceuticals defined
  • B. Pharmaceutical packaging defined
  • C. Study organization
  • D. Methodology
  • E. Geographic regions
  • F. Conventions

Section II: Technology

  • A. Technology priorities
    • 1. Drug safety and efficacy
    • 2. Drug sensitivity
    • 3. Drug delivery method
    • 4. Regulations drug safety and efficacy
    • 5. Packaging cost
    • 6. Environment and health
    • 7. Packaging requirements
  • B. Devices versus packages definition
    • 1. Inhalers
    • 2. Pen injection systems
    • 3. Auto-injectors
    • 4. Wearable devices
  • C. Primary packaging
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. Intravenous (IV) bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other primary containers
    • 13. Closures
    • 14. Innerseals
  • D. Secondary packaging
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • E. Child-resistant packaging
    • 1. Multi-dose packaging
    • 2. Unit-dose packaging
    • 3. Additional child-resistant technologies
  • F. Compliance packaging
    • 1. Calender blister pack
    • 2. Dose indicators
    • 3. Electronic compliance monitoring (ECM)
    • 4. ECM closure
    • 5. ECM blister pack
    • 6. Wallet
    • 7. Summary
  • G. Tamper-evident packaging
    • 1. Inherently tamper-evident packages
    • 2. Not inherently tamper evident
    • 3. Pre-filled syringes
  • H. Unit-dose packaging
  • I. Anti-counterfeit packaging
    • 1. Existing solutions
    • 2. Serialization
  • J. Labeling
  • K. Identification and tracking
    • 1. Barcodes
    • 2. Radio frequency identification (RFID)
    • 3. Near field communications
  • L. Active packaging
  • M. Packaging processes for sterile drugs
    • 1. Traditional aseptic packaging
    • 2. Aseptic packaging with barrier isolation technology
    • 3. Terminal sterilization (in-package sterilization)
  • N. Packaging processes for non-sterile drugs
  • O. Pharmaceutical packaging materials
    • 1. Polymers
    • 2. Glass
    • 3. Aluminum foil
    • 4. Paper
    • 5. Paperboard
    • 6. Other
  • P. Pharmaceutical packaging structures
    • 1. Blister pack structures
    • 2. Bottles, vials, ampules, cartridges, and mini-jars
    • 3. Pouch structures
    • 4. Pre-filled syringes
    • 5. IV bags
    • 6. Tube structures
    • 7. Secondary packaging
    • 8. Other structures
  • Q. Pharmaceutical packaging equipment technology
    • 1. Filling equipment
    • 2. Filling equipment suppliers

Section III: Market Trends and Projections

  • A. Pharmaceutical industry drivers and trends
    • 1. Government policies
    • 2. Macro environment
    • 3. New drugs
    • 4. New drug delivery techniques
    • 5. Biologics
    • 6. Generic drugs
    • 7. Delivery devices
    • 8. New drug production techniques
  • B. Pharmaceutical packaging industry drivers and trends
    • 1. Underlying product trends
    • 2. Regulatory environment
    • 3. Government healthcare programs
    • 4. Product differentiation
    • 5. Drug safety
    • 6. Conversions from prescription to OTC
    • 7. Alternative drug delivery methods
    • 8. Environmental
    • 9. Drug protection requirements
  • C. Global primary packaging volume by delivery method
    • 1. Cutaneous
    • 2. Inhaled
    • 3. Nasal
    • 4. Ocular
    • 5. Oral delivery
    • 6. Parenteral
    • 7. Transdermal
    • 8. Other
  • D. Global primary packaging volume by package type
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. IV bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other
    • 13. Closures
    • 14. Innerseals
  • E. Global primary packaging value segmented by package type
  • F. Asia primary packaging volume by packaging type
  • G. China primary packaging volume by packaging type
  • H. Europe primary packaging volume by packaging type
  • I. Japan primary packaging volume by packaging type
  • J. North America primary packaging volume by package type
  • K. ROW primary packaging volume by packaging type
  • L. Global primary packaging volume by geographic region
    • 1. Asia
    • 2. China
    • 3. Europe
    • 4. Japan
    • 5. North America
    • 6. Rest of World (ROW)
  • M. Global primary packaging value by geographic region
  • N. Global secondary packaging volume by package type
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • O. Global secondary packaging value by package type
  • P. Primary packaging volume segmented by regulatory status
    • 1. Over-the-counter pharmaceuticals
    • 2. Prescription
    • 3. Projection
  • Q. Primary packaging volume by drug production process
    • 1. Chemical
    • 2. Biological
    • 3. Projection
  • R. Primary packaging volume by distribution channel
    • 1. Institutional
    • 2. Retail
    • 3. Projection
  • S. Primary packaging volume segmented by compliance features
    • 1. Compliance
    • 2. Projection
  • T. Primary packaging volume segmented by anti-counterfeiting
    • 1. Anti-counterfeit
    • 2. Projection
  • U. Primary packaging volume by child resistance
    • 1. Child resistance
    • 2. Projection
  • V. Primary packaging volume by tamper evidence
    • 1. Tamper evidence
    • 2. Projection
  • W. Primary packaging volume segmented by material type
    • 1. Primary packaging
    • 2. Blister pack
    • 3. Tubes
    • 4. Pouches and strip packs
    • 5. Secondary packaging

Section IV: Packaging Producers

Section V: Equipment Suppliers

Section VI: Glossary

Back to Top